2026 ICD-10-CM Diagnosis Code R87.614Cytologic evidence of malignancy on smear of cervix
ICD-10-CM Codes›R00–R99›R83-R89›R87
- Billable — Valid for Submission
- Chronic Condition
R87.614 is a billable ICD-10-CM diagnosis code for cytologic evidence of malignancy on smear of cervix. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 742 through 743, 760 through 761. As a symptom code, it should not be used as a principal diagnosis once a related definitive diagnosis has been established. Coders also document this condition as cytological evidence of malignancy on cervical Papanicolaou smear. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Abnormal findings without diagnosis.
Code Identity
Code Classification
Approximate SynonymsGuidance
Alternate terms and clinical phrases that map to this code.
- Cytological evidence of malignancy on cervical Papanicolaou smear
- Detected by cytology
- Malignant neoplasm detected by Papanicolaou smear of cervix
Index to Diseases and InjuriesGuidance
Alphabetical index entries that point to this code.
- Abnormal, abnormality, abnormalities - See Also: Anomaly;
- cytologic evidence of malignancy - R87.614
- Evidence
- of malignancy on cervical smear - R87.614
External Cause of Injuries IndexGuidance
References for this code in the External Cause of Injuries Index.
- Abnormal, abnormality, abnormalities
- Papanicolaou (smear)
- cervix
- cytologic evidence of malignancy
- Evidence
- cytologic
- of malignancy on cervical smear
Clinical ClassificationClinical
AHRQ’s CCSR groups this code into broader clinical categories.
Patient EducationClinical
Cervical Cancer
Cervical cancer is cancer that starts in the cells of the cervix. The cervix is part of the female reproductive system. It is the lower, narrow end of the uterus (womb), which opens into the vagina (birth canal).
The full article covers:
- What is cervical cancer?
- What causes cervical cancer?
- Who is more likely to develop cervical cancer?
- What are the symptoms of cervical cancer?
- How is cervical cancer diagnosed?
- What are the treatments for cervical cancer?
- Can cervical cancer be prevented?
Read the full article at MedlinePlus
Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.
Convert R87.614 to ICD-9-CMHistory
The closest ICD-9-CM equivalents under the General Equivalence Mappings.
Code HistoryHistory
Questions About R87.614Overview
Is R87.614 (Abnormal cytological findings in specimens from cervix uteri) a billable code?
Yes. This is a billable ICD-10-CM code, specific enough to report cytologic evidence of malignancy on smear of cervix on HIPAA-covered claims from October 1, 2025 through September 30, 2026.
What MS-DRG does R87.614 group to?
When cytologic evidence of malignancy on smear of cervix is the principal diagnosis on an inpatient stay, it groups to MS-DRG 742, 743, 760, 761, with relative weights from 0.5696 to 1.8348 depending on complications. Higher weights mean higher Medicare reimbursement.
Can R87.614 be a principal diagnosis?
Use it with care. This is a symptom code, so once a definitive diagnosis explaining the cytologic evidence of malignancy on smear of cervix is established, that condition takes the principal position instead.
What is the ICD-9 equivalent of R87.614?
Under the General Equivalence Mappings, cytologic evidence of malignancy on smear of cervix converts to ICD-9-CM 795.06 (pap smr cytol evid malig). The mapping is a direct match.
Footnotes
[1] Chronic - a chronic condition code indicates a condition lasting 12 months or longer and its effect on the patient based on one or both of the following criteria:
- The condition results in the need for ongoing intervention with medical products,treatment, services, and special equipment
- The condition places limitations on self-care, independent living, and social interactions.
